IRIS
PANE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 564
EU - Europa 302
AS - Asia 97
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 560
IT - Italia 176
CN - Cina 62
NL - Olanda 42
IE - Irlanda 22
IN - India 13
CI - Costa d'Avorio 12
DE - Germania 12
BG - Bulgaria 11
FI - Finlandia 11
GB - Regno Unito 10
CA - Canada 4
CH - Svizzera 4
HK - Hong Kong 4
JP - Giappone 4
PH - Filippine 4
SE - Svezia 4
TR - Turchia 4
UA - Ucraina 4
VN - Vietnam 4
MK - Macedonia 3
AP - ???statistics.table.value.countryCode.AP??? 1
CO - Colombia 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
IR - Iran 1
SG - Singapore 1
Totale 978
Salva come PNG Salva come JPEG
Città #
Chandler 143
Ashburn 62
Amsterdam 40
Naples 30
Millbury 26
Beijing 25
Nanjing 24
Dearborn 18
Des Moines 18
Seattle 18
Napoli 17
Princeton 16
Nola 13
Boston 12
Sofia 11
Lawrence 10
Norwalk 10
Cava De' Tirreni 8
Gricignano di Aversa 7
Wilmington 7
Pune 6
Monteforte Irpino 5
Rome 5
Dong Ket 4
Fairfield 4
Hong Kong 4
Izmir 4
Lviv 4
Ottawa 4
Redwood City 4
Torre Annunziata 4
Washington 4
Battipaglia 3
Bitola 3
Dublin 3
General Mariano Alvarez 3
Houston 3
Brusciano 2
Davis 2
Florence 2
Marsala 2
Milan 2
Parma 2
Pompei 2
Portici 2
Sassari 2
Secunderabad 2
Shenyang 2
Tianjin 2
Turin 2
Whitby 2
Atlanta 1
Bern 1
Boardman 1
Caserta 1
Changchun 1
Eboli 1
Esslingen am Neckar 1
Guangzhou 1
Hebei 1
Hefei 1
High Point 1
Indiana 1
Kolkata 1
Kronberg 1
Kunming 1
Lanzhou 1
Leawood 1
London 1
Los Angeles 1
Madrid 1
Messina 1
Mumbai 1
Nanchang 1
Rochester 1
Sabz 1
San Giuseppe Vesuviano 1
San Jose 1
San Mateo 1
Sant'agata De' Goti 1
Sant'arpino 1
Scafati 1
Singapore 1
Tamm 1
Torino 1
Verona 1
Woodbridge 1
Xian 1
Totale 647
Salva come PNG Salva come JPEG
Nome #
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 56
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 51
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 51
The use of medical-grade cannabis in patients non-responders to Nabiximols 50
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 50
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 49
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 48
Prevalence and features of non-motor symptoms in Wilson's disease 44
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 43
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 43
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 41
Peripheral markers of autophagy in polyglutamine diseases 41
Adult normative values for the PATA Rate Test 40
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 40
A randomized clinical trial of lithium in multiple system atrophy. 39
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 38
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 36
Mobitz type I and II atrioventricular blocks during fingolimod therapy 36
Fingolimod first dose safety in clinical practice. 27
The Multiple Faces of Spinocerebellar Ataxia type 2 26
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 23
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 23
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 22
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 22
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 21
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 21
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 20
The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series 16
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 11
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes. 11
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group 5
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A 3
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 3
Nonvascular Parkinsonism in Fabry Disease: Results from Magnetic Resonance and Dopamine Transporter Imaging 2
Totale 1.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 3 0
2019/2020122 26 16 0 0 5 4 21 5 4 26 14 1
2020/202142 5 0 1 9 0 4 2 2 8 0 6 5
2021/2022188 3 6 1 1 5 10 6 5 31 13 37 70
2022/2023344 36 37 13 19 40 33 9 28 58 52 16 3
2023/2024195 7 33 17 21 14 25 13 55 7 2 1 0
Totale 1.052